US00509G2093
US00509G2093
Acumen Pharmaceuticals, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 123.832.000 | 114.017.000 | 8.6% | |
| Operating Income | -123.832.000 | -114.017.000 | 8.6% |
| Pretax Income | -121.335.000 | -102.329.000 | 18.6% |
| Net Income Common Stockholders | -121.335.000 | -102.329.000 | 18.6% |
| -- | -- | -- | |
| -- | -- | -- |